Alissa Hsu Lynch, VP, GM for Valeant Consumer Products, recently talked with Drug Store News about the company's unique marketing approach behind the CeraVe brand and shared her insights on some of the hottest skin care trends on the horizon.
Actavis and Valeant Pharmaceuticals International announced that the Food and Drug Administration approved the new drug application for Metronidazole 1.3% vaginal gel. The antibiotic is used for the treatment of bacterial vaginosis, an infection caused by an imbalance in the normal bacteria of vagina.
Valeant Pharmaceuticals International on Thursday announced the expiration of the tender offer by a subsidiary of Valeant Pharmaceuticals International to purchase all of the outstanding shares of Solta Medical for $2.92 per share in cash, without interest (less any applicable withholding taxes).
AMBI Skincare, which recently joined Valeant Pharmaceuticals North America, has added Jeanine B. Downie, a board-certified dermatologist with an active practice in New Jersey, New York and California, as a skin of color expert for the brand.
“Why do smart leaders fail? They go off track with lack of strategic decisiveness, failure to create systems driving execution, struggle with financial management or talent retention. The top leaders create a virtual board of advisers to help them stay in reality.” That was one of the key messages conveyed by Elevation Forum founder Dan Mack to more than 30 senior leaders prior to the GMDC event in San Antonio.
Actavis is continuing to pursue a plan to buy Irish drug maker Warner Chilcott, as the U.S.-based company announced Tuesday its total number of shares and share-purchase options in order to comply with Ireland's merger-and-acquisition rules.